Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned

Varvara A Ryabkova, Leonid P Churilov, Yehuda Shoenfeld

Результат исследований: Научные публикации в периодических изданияхОбзорная статьярецензирование

4 Цитирования (Scopus)

Аннотация

The outbreak of COVID-19 reminds us that the emerging and reemerging respiratory virus infections pose a continuing threat to human life. Cytokine storm syndromes of viral origin seem to have a common pathogenesis of the imbalanced immune response with the exaggerated inflammatory reaction combined with the reduction and functional exhaustion of T cells. Immunomodulatory therapy is gaining interest in COVID-19, but this strategy has received less attention in other respiratory viral infections than it deserved. In this review we suggest that based on the similarities of the immune dysfunction in the severe cases of different respiratory viral infections, some lessons from the immunomodulatory therapy of COVID-19 (particularly regarding the choice of an immunomodulatory drug, the selection of patients and optimal time window for this kind of therapy) could be applied for some cases of severe influenza infection and probably for some future outbreaks of novel severe respiratory viral infections.

Язык оригиналаанглийский
Номер статьи108652
ЖурналClinical Immunology
Том223
Ранняя дата в режиме онлайндек 2020
DOI
СостояниеОпубликовано - 2021

Предметные области Scopus

  • Медицина (все)

Fingerprint

Подробные сведения о темах исследования «Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned». Вместе они формируют уникальный семантический отпечаток (fingerprint).

Цитировать